DNA Biobank "Miras", Kazakhstan

Registration Status: Pending

Objective: The aim of biobank is to identify genetic markers and improve prevention, diagnosis and treatment of life-threatening illnesses – including heart diseases, stroke, diabetes, depression, pregnancy complications and etc. «Miras» Biobank was established in the frame of EC 7th FP «Genetic studies of pre-eclampsia (PE) in Central Asian and European populations» 2012-2016 №282540.

Registered Biobank Name DNA Biobank "Miras"
Biobank Leader Gulnara Svyatova
Country Kazakhstan
Email for biobank inquiries respmgk@mail.ru
Principal Investigator Gulnara Svyatova
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Oligo - Collection aimed at supporting several research projects, a research group or a research consortium
Biospecimen Collected: